With 0.64 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.7 million shares. During the session, the Banks – Regional company that operates in wider Financial sector, reached to the highest price of $28.84 whereas the lowest price it dropped to was $28.34. The 52-week range on UCB shows that it touched its highest point at $35.38 and its lowest point at $24.04 during that stretch. It currently has a 1-year price target of $36.00. With its current market cap of 3.41 billion, UCB has annualized dividend of $0.95 while the current yield stands at 3.33%. UCB paid its most recent dividend on 1741910400, while the ex-dividend date for that was 1741910400. Beta for the stock currently stands at 0.80.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of UCB was up-trending over the past week, with a rise of 1.53%, but this was down by -8.84% over a month. Three-month performance dropped to -10.19% while six-month performance fell -1.04%. The stock gained 14.25% in the past year, while it has lost -11.64% so far this year. A look at the trailing 12-month EPS for UCB yields 2.04 with Next year EPS estimates of 2.69. For the next quarter, that number is 0.56. This implies an EPS growth rate of 6.10% for this year and 10.25% for next year.
Float and Shares Shorts:
At present, 119.36 million UCB shares are outstanding with a float of 118.56 million shares on hand for trading. On 2025-03-14, short shares totaled 3.77 million, which was 315.0 higher than short shares on 1739491200. In addition to Mr. Herbert Lynn Harton as the firm’s Chairman & CEO, Mr. Jefferson Lee Harralson C.F.A. serves as its Executive VP & CFO.
Institutional Ownership:
Through their ownership of 0.87858003 of UCB’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With UCB analysts setting a high price target of 39.0 and a low target of 32.0, the average target price over the next 12 months is 36.0. Based on these targets, UCB could surge 36.6% to reach the target high and rise by 12.08% to reach the target low. Reaching the average price target will result in a growth of 26.09% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $2.27013 being high and $2.20987 being low. For UCB, this leads to a yearly average estimate of $2.24. Based on analyst estimates, the high estimate for the next quarter is $0.62 and the low estimate is $0.55. The average estimate for the next quarter is thus $0.59.
